drugset / Trial / NCT00660517

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

NCT00660517

Phase 3 Completed 607 enrolled Meda Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if two allergy medications (azelastine and fluticasone) are more effective than placebo or either medication alone (azelastine or fluticasone)

Timeline

Start
2007-12
Primary completion
2008-02
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azelastine Small molecule 548 ug Other
Comparator Fluticasone propionate Other / unclassified 200 ug Other